Cyclerion and Korsana announce merger
“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment
Positive results from moderate-to-severe atopic dermatitis trial
Centessa Pharmaceuticals to be acquired by Lilly
Neuroblastoma treatment receives Orphan Drug Designation
Base to Base biotech podcast 30: Life sciences in Lithuania
Encouraging results from Canavan disease trial
Collaboration to address CAR-T cell therapy for brain cancer
Precision Cell Systems acquires BennuBio
Blood test for chronic fatigue syndrome unveiled
New antibiotic targets IBD
First gene therapy for rare subtype of Charcot-Marie-Tooth disease clears hurdle